Suggestions
Share
Journal Information

Statistics

Follow this link to access the full text of the article

SELECTIVE TARGETING OF FCRN AND IGG CLEARANCE BY NIPOCALIMAB PRESERVES KEY IMMUNE FUNCTIONS
LE Linga, S Tylerb, CJ Beneducea, F Yua, J Browna, S Kumarc, R Xua, J Duffnerd, AB Perdomoe, W Averyf
a Janssen Research and Development, LLC
b Orna Therapeutics
c Checkmate Pharmaceuticals
d Faze Medicines, Cambridge, United States
e Immunology Medical Affairs, Janssen Latin America
f Kisbee Therapeutics
Read
2280
Times
was read the article
936
Total PDF
1344
Total HTML
Share statistics
Article information
ISSN: 25311379
Original language: English
The statistics are updated each day
Year/Month Html Pdf Total
2025 12 190 102 292
2025 11 93 54 147
2025 10 57 48 105
2025 9 62 33 95
2025 8 45 27 72
2025 7 62 22 84
2025 6 48 18 66
2025 5 51 15 66
2025 4 43 16 59
2025 3 55 15 70
2025 2 38 23 61
2025 1 34 29 63
2024 12 29 13 42
2024 11 24 30 54
2024 10 26 18 44
2024 9 32 20 52
2024 8 41 22 63
2024 7 28 21 49
2024 6 36 32 68
2024 5 41 24 65
2024 4 29 16 45
2024 3 18 24 42
2024 2 21 31 52
2024 1 13 15 28
2023 12 14 20 34
2023 11 22 24 46
2023 10 15 36 51
2023 9 17 23 40
2023 8 17 16 33
2023 7 16 9 25
2023 6 20 21 41
2023 5 15 13 28
2023 4 15 12 27
2023 3 12 14 26
2023 2 15 14 29
2023 1 12 11 23
2022 12 21 28 49
2022 11 14 18 32
2022 10 3 9 12
Show all

Follow this link to access the full text of the article

Idiomas
Hematology, Transfusion and Cell Therapy